Cargando…
Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies
An effective malaria vaccine remains a global health priority and vaccine immunogens which prevent transmission of the parasite will have important roles in multi-component vaccines. One of the most promising candidates for inclusion in a transmission-blocking malaria vaccine is the gamete surface p...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509318/ https://www.ncbi.nlm.nih.gov/pubmed/36153317 http://dx.doi.org/10.1038/s41467-022-33379-6 |
_version_ | 1784797212628221952 |
---|---|
author | Ko, Kuang-Ting Lennartz, Frank Mekhaiel, David Guloglu, Bora Marini, Arianna Deuker, Danielle J. Long, Carole A. Jore, Matthijs M. Miura, Kazutoyo Biswas, Sumi Higgins, Matthew K. |
author_facet | Ko, Kuang-Ting Lennartz, Frank Mekhaiel, David Guloglu, Bora Marini, Arianna Deuker, Danielle J. Long, Carole A. Jore, Matthijs M. Miura, Kazutoyo Biswas, Sumi Higgins, Matthew K. |
author_sort | Ko, Kuang-Ting |
collection | PubMed |
description | An effective malaria vaccine remains a global health priority and vaccine immunogens which prevent transmission of the parasite will have important roles in multi-component vaccines. One of the most promising candidates for inclusion in a transmission-blocking malaria vaccine is the gamete surface protein Pfs48/45, which is essential for development of the parasite in the mosquito midgut. Indeed, antibodies which bind Pfs48/45 can prevent transmission if ingested with the parasite as part of the mosquito bloodmeal. Here we present the structure of full-length Pfs48/45, showing its three domains to form a dynamic, planar, triangular arrangement. We reveal where transmission-blocking and non-blocking antibodies bind on Pfs48/45. Finally, we demonstrate that antibodies which bind across this molecule can be transmission-blocking. These studies will guide the development of future Pfs48/45-based vaccine immunogens. |
format | Online Article Text |
id | pubmed-9509318 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-95093182022-09-26 Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies Ko, Kuang-Ting Lennartz, Frank Mekhaiel, David Guloglu, Bora Marini, Arianna Deuker, Danielle J. Long, Carole A. Jore, Matthijs M. Miura, Kazutoyo Biswas, Sumi Higgins, Matthew K. Nat Commun Article An effective malaria vaccine remains a global health priority and vaccine immunogens which prevent transmission of the parasite will have important roles in multi-component vaccines. One of the most promising candidates for inclusion in a transmission-blocking malaria vaccine is the gamete surface protein Pfs48/45, which is essential for development of the parasite in the mosquito midgut. Indeed, antibodies which bind Pfs48/45 can prevent transmission if ingested with the parasite as part of the mosquito bloodmeal. Here we present the structure of full-length Pfs48/45, showing its three domains to form a dynamic, planar, triangular arrangement. We reveal where transmission-blocking and non-blocking antibodies bind on Pfs48/45. Finally, we demonstrate that antibodies which bind across this molecule can be transmission-blocking. These studies will guide the development of future Pfs48/45-based vaccine immunogens. Nature Publishing Group UK 2022-09-24 /pmc/articles/PMC9509318/ /pubmed/36153317 http://dx.doi.org/10.1038/s41467-022-33379-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Ko, Kuang-Ting Lennartz, Frank Mekhaiel, David Guloglu, Bora Marini, Arianna Deuker, Danielle J. Long, Carole A. Jore, Matthijs M. Miura, Kazutoyo Biswas, Sumi Higgins, Matthew K. Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies |
title | Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies |
title_full | Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies |
title_fullStr | Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies |
title_full_unstemmed | Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies |
title_short | Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies |
title_sort | structure of the malaria vaccine candidate pfs48/45 and its recognition by transmission blocking antibodies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509318/ https://www.ncbi.nlm.nih.gov/pubmed/36153317 http://dx.doi.org/10.1038/s41467-022-33379-6 |
work_keys_str_mv | AT kokuangting structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies AT lennartzfrank structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies AT mekhaieldavid structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies AT guloglubora structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies AT mariniarianna structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies AT deukerdaniellej structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies AT longcarolea structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies AT jorematthijsm structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies AT miurakazutoyo structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies AT biswassumi structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies AT higginsmatthewk structureofthemalariavaccinecandidatepfs4845anditsrecognitionbytransmissionblockingantibodies |